http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016033484-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ecf631ba60ae8b9030ffa82318ae99ea |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-368 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5091 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5032 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate | 2015-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_750de616c7ecbce73d0806ac249cd726 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1027a116f2abc73745cc52ec81071cf3 |
| publicationDate | 2016-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2016033484-A1 |
| titleOfInvention | Serum-based, diagnostic, biological assay to predict pregnancy disorders |
| abstract | The invention provides serum-based, diagnostic, biological assays for predicting disorders of pregnancy resulting from poor trophoblast and/or placental ischemia, including preeclampsia. Serum samples from such subjects exhibit an ability to disrupt the architecture involving fetal trophoblasts and maternal endothelial cells in a three-dimensional, dual cell co-culture system provided herein, in contrast to normal pregnancy serum samples. Based on these distinctions, the assays are employed to predict pregnancy outcomes as early as first trimester. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018090467-A1 |
| priorityDate | 2008-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 386.